JP2003501110A5 - - Google Patents

Download PDF

Info

Publication number
JP2003501110A5
JP2003501110A5 JP2001502873A JP2001502873A JP2003501110A5 JP 2003501110 A5 JP2003501110 A5 JP 2003501110A5 JP 2001502873 A JP2001502873 A JP 2001502873A JP 2001502873 A JP2001502873 A JP 2001502873A JP 2003501110 A5 JP2003501110 A5 JP 2003501110A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
vaccine
seq
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001502873A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003501110A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/015925 external-priority patent/WO2000076540A2/en
Publication of JP2003501110A publication Critical patent/JP2003501110A/ja
Publication of JP2003501110A5 publication Critical patent/JP2003501110A5/ja
Pending legal-status Critical Current

Links

JP2001502873A 1999-06-10 2000-06-09 肺炎連鎖球菌タンパク質とワクチン Pending JP2003501110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13845399P 1999-06-10 1999-06-10
US60/138,453 1999-06-10
PCT/US2000/015925 WO2000076540A2 (en) 1999-06-10 2000-06-09 Streptococcus pneumoniae proteins and vaccines

Publications (2)

Publication Number Publication Date
JP2003501110A JP2003501110A (ja) 2003-01-14
JP2003501110A5 true JP2003501110A5 (enExample) 2007-08-16

Family

ID=22482080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001502873A Pending JP2003501110A (ja) 1999-06-10 2000-06-09 肺炎連鎖球菌タンパク質とワクチン

Country Status (9)

Country Link
EP (2) EP1185297B1 (enExample)
JP (1) JP2003501110A (enExample)
AT (2) ATE325620T1 (enExample)
AU (1) AU777856B2 (enExample)
CA (1) CA2371714C (enExample)
DE (2) DE60027890T2 (enExample)
ES (2) ES2264419T3 (enExample)
HK (1) HK1043943A1 (enExample)
WO (1) WO2000076540A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135560B1 (en) 1997-07-02 2006-11-14 Sanofi Pasteur Limited Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
AU2002351623A1 (en) 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
PL3017827T3 (pl) 2005-12-22 2019-04-30 Glaxosmithkline Biologicals Sa Szczepionka z koniugatem polisacharydu pneumokokowego
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
US9610339B2 (en) 2007-06-26 2017-04-04 Glaxosmithkline Biologicals, S.A. Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
NZ586367A (en) 2007-12-13 2012-04-27 Intervacc Ab Improved immunizing composition comprising an antigen from Streptococcus equi
PL2268618T3 (pl) 2008-03-03 2015-11-30 Novartis Ag Związki i kompozycje jako modulatory aktywności receptorów TLR
PL2271360T3 (pl) 2008-04-16 2016-03-31 Glaxosmithkline Biologicals Sa Szczepionka
CN102762226A (zh) 2009-06-10 2012-10-31 诺华有限公司 含苯并萘啶的疫苗
MX2012000158A (es) 2009-06-29 2012-06-08 Genocea Biosciences Inc Vacunas y composiciones contra streptococcus pneumoniae.
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
US20120237536A1 (en) 2009-09-10 2012-09-20 Novartis Combination vaccines against respiratory tract diseases
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
JP5848748B2 (ja) 2010-03-23 2016-01-27 アイアールエム・リミテッド・ライアビリティ・カンパニーIrm,Llc 感染症、炎症、呼吸器疾患などの処置に使用するtlr2アゴニストとしての化合物(システインベースのリポペプチド)および組成物
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
CN105833260A (zh) 2011-01-20 2016-08-10 健诺西生物科学公司 针对肺炎链球菌(Streptococcus Pneumoniae)的疫苗和组合物
BR112013029514A2 (pt) 2011-05-17 2019-09-24 Glaxosmithkline Biologicals Sa composição imunogênica, vacina, e, método de tratar ou impedir uma doença
JP2015510872A (ja) 2012-03-07 2015-04-13 ノバルティス アーゲー Streptococcuspneumoniae抗原の増強された製剤
TR201807340T4 (tr) 2013-02-01 2018-06-21 Glaxosmithkline Biologicals Sa Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
IL276608B2 (en) 2018-02-12 2024-04-01 Inimmune Corp Toll-like receptor ligands
JP2023547676A (ja) 2020-11-04 2023-11-13 エリゴ・バイオサイエンス DNAペイロードをアクネ菌集団へとin situ送達するためのファージ由来粒子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018931A2 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
EP1144640A3 (en) * 1998-07-27 2001-11-28 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae

Similar Documents

Publication Publication Date Title
JP2003501110A5 (enExample)
CA2371714A1 (en) Streptococcus pneumoniae proteins and vaccines
JP2003515323A5 (enExample)
JP2006525330A5 (enExample)
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
RU2006127314A (ru) Вакцина, стимулирующая рост, основанная на нейтрализующем эпитопе
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
JP2002505843A5 (enExample)
CA2674885A1 (en) Anti-ige vaccines
EP2292645A3 (en) Small Streptococcus pyogenes antigens and their use
JP2003530872A5 (enExample)
NO20011381L (no) Preparater av streptokokk C<beta>-protein
IL127595A0 (en) Polypeptides capable of forming antigen binding structures with specificity for the rhesus D antigens the DNA encoding them and the process for their preparation and use
JP2002534481A5 (enExample)
JP2003531634A5 (enExample)
AU702294B2 (en) Proteins from mammalian liver and their use in oncology
EP1546357B1 (en) Immunogenic mycoplasma hyopneumoniae polypeptides
DK200601181A (da) Fiskevaccine
CA2411949A1 (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
CA2967778A1 (en) Anti-thyroglobulin t cell receptors
CN103724413B (zh) 旋毛虫副肌球蛋白b细胞抗原表位8a1及其应用
IL125645A0 (en) Recombinant phages
KR970070198A (ko) 항-파스 재조합 항체 및 이에 대한 디엔아이
CA2411919A1 (en) Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
CA2475821A1 (en) Group b streptococcus antigens